Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Behavioral Therapy (CBT-I) Augmentation of Topiramate in Promoting Abstinence in Alcohol Use Disorder (AUD)

NCT04581603 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT04581603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04581603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Behavioral Therapy (CBT-I) Augmentation of Topiramate in Promoting Abstinence in Alcohol Use Disorder (AUD)
Lead sponsor
VA Office of Research and Development
Phase
Phase 4
Overall status
Terminated
Start date
June 15, 2022
Completion date
January 20, 2025
Enrollment
82 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder with insomnia